Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery
1 other identifier
interventional
202
1 country
1
Brief Summary
Postoperative nausea and vomiting (PONV) is related with extended hospital day and risk factor of aspiration pneumonia. Postoperative patient controlled intravenous analgesia is related with postoperative nausea and vomiting. Selective 5-HT3 antagonist, Palonosetron, is the most recent medication for prevention of PONV. Purpose of our study is comparison of PONV preventive effect of palonosetron and combination of palonosetron and dexamethasone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 24, 2015
CompletedFirst Submitted
Initial submission to the registry
April 18, 2016
CompletedFirst Posted
Study publicly available on registry
April 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2017
CompletedJune 20, 2018
June 1, 2018
1.7 years
April 18, 2016
June 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of clinically significant PONV with PONV impact scale
72 hours
Study Arms (2)
P group
ACTIVE COMPARATORPalonosetron group
PD group
EXPERIMENTALPalonosetron and dexamethasone group
Interventions
Eligibility Criteria
You may qualify if:
- patients who are undergoing minor orthopedic surgery.
- IV patient controlled analgesia
You may not qualify if:
- \. minority (0\~19 year)
- patients who are belongs to ASA class 3 or more, and have underlying complicated cardiovascular or psychological disease.
- Steroid medication
- Diabetes Mellitus medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine
Seoul, 03722, South Korea
Related Publications (1)
Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5. doi: 10.1093/oxfordjournals.bja.a013366.
PMID: 10740540BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2016
First Posted
April 20, 2016
Study Start
July 24, 2015
Primary Completion
March 20, 2017
Study Completion
March 20, 2017
Last Updated
June 20, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share